-
Mashup Score: 7
Northwestern Medicine scientists have developed a method for identifying reactive cysteines on peptide antigens within the immune system, a development which may prove useful in cancer immunotherapy, according to a study published in Nature Communications.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 11
A new blood test may help reduce unnecessary prostate biopsies and can detect prostate cancer with similar sensitivity to standard screening in patients across racial and ethnic groups, according to a recent study published in the Journal of Clinical Oncology.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet-
A new blood test may reduce unnecessary biopsies and detect #prostatecancer with similar sensitivity to PSA in patients across racial and ethnic groups, per @DrAdamMurphy of @LurieCancer, lead author of the multi-center clinical trial in @JCO_ASCO. https://t.co/eMHiNlARIE… https://t.co/ZO7nf6Cea0 https://t.co/ZV3ziw4Za9
-
-
Mashup Score: 8Decreasing Fatigue in Patients with Advanced Breast Cancer - 15 day(s) ago
Acceptance and commitment therapy significantly decreased fatigue interference and improved quality of life in patients with metastatic breast cancer six months after treatment, according to recent findings published in the Journal of Clinical Oncology.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet-
Acceptance and commitment therapy (ACT) significantly decreased fatigue and improved quality of life in patients with metastatic #breastcancer, according to Elizabeth Addington, PhD, co-author of a recent study in @JCO_ASCO. https://t.co/PhSxsPDsMR via @NUFeinbergMed #BCSM https://t.co/plOQX6Koh1
-
-
Mashup Score: 11Combination Therapy Does Not Extend Survival in Glioblastoma - 1 month(s) ago
Patients with a subtype of glioblastoma who received a combination treatment of a PARP inhibitor and standard chemotherapy did not demonstrate improved survival compared to chemotherapy and placebo, according to a recent clinical trial published in JAMA Oncology.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet-
Combination treatment of a PARP inhibitor and standard chemotherapy did not extend survival for patients with a subtype of #glioblastoma according to a recent clinical trial in @JAMAOnc, co-authored by Priya Kumthekar, MD. https://t.co/kscVZXLFgQ via @NUFeinbergMed #BTSM
-
-
Mashup Score: 4Immunotherapy Shows Potential to Treat Deadly Thyroid Cancer - 1 month(s) ago
A type of immunotherapy appears to be effective in treating a deadly subset of thyroid cancer, according to the results of a clinical trial published in JAMA Oncology.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet-
Dual immune checkpoint inhibitors show potential for patients with advanced anaplastic thyroid cancer according to @LurieCancer's Jochen Lorch, MD, senior author of a clinical trial published in @JAMAOnc https://t.co/r1OoH5HqeO via @NUFeinbergMed #thyroidcancer
-
-
Mashup Score: 12Accelerating Discoveries in Immunobiology Through Collaboration - 1 month(s) ago
Just two years out from its launch, the Center for Human Immunobiology has quickly become a bustling hub for collaborative efforts to understand the molecular mechanisms of the immune system and translate discoveries into innovative cures for immune-regulated diseases.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet-
Led by Lurie Cancer Center member, @StephanieEisen, the Center for Human Immunobiology at @NUFeinbergMed is uncovering the mysteries of the immune system through collaboration. https://t.co/FV6sSxrV1S @immunology_nu https://t.co/XPLAmWWQM6
-
-
Mashup Score: 0
Northwestern scientists, clinicians, and members of the ALS community gathered in the Feinberg Pavilion for the 14th annual Les Turner Symposium on ALS to celebrate progress and share the latest research in hopes of better understanding and treating the disease.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Rare DiseaseTweet-
Les Turner Symposium on ALS Unites Community Around Research and Patient Care https://t.co/EQIAP7tgOh
-
-
Mashup Score: 12Improving the Science and Treatment of Glioblastoma - 2 month(s) ago
The average length of survival for glioblastoma has failed to improve since it was first identified in scientific literature nearly 100 years ago. Despite this, scientists at Feinberg remain steadfast in their commitment to improving the understanding and treatment of glioblastoma through rigorous research initiatives and clinical trials.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet-
Through rigorous research initiatives and clinical trials, @LurieCancer scientists at @NUFeinbergMed are improving the understanding of #glioblastoma and developing new targeted treatment approaches. ➡️ https://t.co/wtjp7bqe4d #braintumor #btsm https://t.co/j71HDh4wUa
-
-
Mashup Score: 15
Northwestern Medicine investigators have discovered that a novel combination treatment promotes cancer cell death and tumor regression in mouse models of pancreatic cancer, providing a rationale for testing in future clinical trials, according to recent findings.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet-
Findings from Hidayatullah Munshi, MD, of @LurieCancer highlight the potential of a novel combination therapy as an effective treatment approach for patients with #pancreaticcancer, according to a recent study in @CR_AACR: https://t.co/zRdVrl0L1U via @NUFeinbergMed #KRAS https://t.co/G2bkvZbzE2
-
-
Mashup Score: 14
Northwestern Medicine investigators have discovered that a novel combination treatment promotes cancer cell death and tumor regression in mouse models of pancreatic cancer, providing a rationale for testing in future clinical trials, according to recent findings.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet-
Findings from Hidayatullah Munshi, MD, of @LurieCancer highlight the potential of a novel combination therapy as an effective treatment approach for patients with #pancreaticcancer, according to a recent study in @CR_AACR: https://t.co/zRdVrl0L1U via @NUFeinbergMed #KRAS https://t.co/G2bkvZbzE2
-
A method developed for identifying reactive cysteines on peptide antigens in the immune system may pave the way for more effective cancer #immunotherapy strategies, per findings from Xiaoyu Zhang, PhD, published in @NatureComms. https://t.co/OsAPMJLKKG via @NUFeinbergMed https://t.co/NlEVVKrDfi